Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
J Clin Oncol
; 26(32): 5156-64, 2008 Nov 10.
Article
in En
| MEDLINE
| ID: mdl-18854568
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Lymphoma, Follicular
/
Radioimmunotherapy
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
/
Europa
Language:
En
Journal:
J Clin Oncol
Year:
2008
Document type:
Article
Affiliation country: